{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:41:55Z","timestamp":1790800915399,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:00:00Z","timestamp":1445644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12902-015-0058-6","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T05:32:11Z","timestamp":1445664731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison\u2019s disease \u2013 favourable response to dietary management: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Kristina S","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Louise","family":"Rushworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Torpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,24]]},"reference":[{"issue":"5","key":"58_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","volume":"56","author":"K L\u00f8v\u00e5s","year":"2002","unstructured":"L\u00f8v\u00e5s K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison\u2019s disease. Clin Endocrinol. 2002;56(5):581\u20138.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"58_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0032-1331766","volume":"45","author":"G Meyer","year":"2013","unstructured":"Meyer G, Hackemann A, Penna-Martinez M, Badenhoop K. What affects the quality of life in autoimmune Addison's disease? Horm Metab Res. 2013;45(2):92\u20135.","journal-title":"Horm Metab Res"},{"issue":"9","key":"58_CR3","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1210\/jc.2007-0445","volume":"92","author":"JJ Christiansen","year":"2007","unstructured":"Christiansen JJ, Djurhuus CB, Gravholt CH, Iversen P, Christiansen JS, Schmitz O, et al. Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J Clin Endocrinol Metab. 2007;92(9):3553\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"58_CR4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","volume":"72","author":"B Bleicken","year":"2010","unstructured":"Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B, et al. Influence of hydrocortisone dosage scheme on health\u2010related quality of life in patients with adrenal insufficiency. Clin Endocrinol. 2010;72(3):297\u2013304.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"58_CR5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","volume":"160","author":"K L\u00f8v\u00e5s","year":"2009","unstructured":"L\u00f8v\u00e5s K, Gjesdal CG, Christensen M, Wolff AB, Alm\u00e5s B, Svartberg J, et al. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol. 2009;160(6):993\u20131002.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"58_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","volume":"270","author":"S Bj\u00f6rnsdottir","year":"2011","unstructured":"Bj\u00f6rnsdottir S, S\u00e4\u00e4f M, Bensing S, K\u00e4mpe O, Michaelsson K, Ludvigsson JF. Risk of hip fracture in Addison\u2019s disease: a population\u2010based cohort study. J Intern Med. 2011;270(2):187\u201395.","journal-title":"J Intern Med"},{"issue":"10","key":"58_CR7","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab. 2006;91(10):3954\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"58_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0035-1548869","volume":"47","author":"RL Rushworth","year":"2015","unstructured":"Rushworth RL, Torpy DJ. Modern hydrocortisone replacement regimens in adrenal insufficiency patients and the risk of adrenal crisis. Horm Metab Res. 2015;47(9):637\u201342.","journal-title":"Horm Metab Res"},{"issue":"6","key":"58_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0034-1395680","volume":"47","author":"RL Rushworth","year":"2015","unstructured":"Rushworth RL, Torpy DJ. Adrenal insufficiency in Australia: is it possible that the Use of lower dose, short-acting glucocorticoids has increased the risk of adrenal crises? Horm Metab Res. 2015;47(6):427\u201332.","journal-title":"Horm Metab Res"},{"issue":"7","key":"58_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/11531290-000000000-00000","volume":"49","author":"N Simon","year":"2010","unstructured":"Simon N, Castinetti F, Ouliac F, Lesavre N, Brue T, Oliver C. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets. Clin Pharmacokinet. 2010;49(7):455\u201363.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"58_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"58_CR12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","volume":"63","author":"AW Meikle","year":"1977","unstructured":"Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63(2):200\u20137.","journal-title":"Am J Med"},{"issue":"3","key":"58_CR13","first-page":"403","volume":"100","author":"P Fietta","year":"2006","unstructured":"Fietta P. Glucocorticoids and brain functions. Rivista Di Biologia. 2006;100(3):403\u201318.","journal-title":"Rivista Di Biologia"},{"issue":"3","key":"58_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2265.1997.780907.x","volume":"46","author":"SR Peacey","year":"1997","unstructured":"Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol. 1997;46(3):255\u201361.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"58_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","volume":"46","author":"TA Howlett","year":"1997","unstructured":"Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol. 1997;46(3):263\u20138.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"58_CR16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","volume":"61","author":"PM Mah","year":"2004","unstructured":"Mah PM, Jenkins RC, Rostami\u2010Hodjegan A, Newell\u2010Price J, Doane A, Ibbotson V, et al. Weight\u2010related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol. 2004;61(3):367\u201375.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"58_CR17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/BF03345252","volume":"26","author":"S Laureti","year":"2003","unstructured":"Laureti S, Falorni A, Santeusanio F. Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses. J Endocrinol Investig. 2003;26(11):1071\u20135.","journal-title":"J Endocrinol Investig"},{"issue":"9","key":"58_CR18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/BF03347262","volume":"28","author":"L Barbetta","year":"2005","unstructured":"Barbetta L, Dall\u2019Asta C, Re T, Libe R, Costa E, Ambrosi B. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism. J Endocrinol Investig. 2005;28(9):632\u20137.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"58_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2265.2012.04352.x","volume":"77","author":"B Ekman","year":"2012","unstructured":"Ekman B, Bachrach\u2010Lindstr\u00f6m M, Lindstr\u00f6m T, Wahlberg J, Blomgren J, Arnqvist HJ. A randomized, double\u2010blind, crossover study comparing two\u2010and four\u2010dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin Endocrinol. 2012;77(1):18\u201325.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"58_CR20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03345290","volume":"27","author":"N Alonso","year":"2004","unstructured":"Alonso N, Granada ML, Lucas A, Salinas I, Reverter J, Oriol A, et al. Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters. J Endocrinol Investig. 2004;27(5):449\u201354.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"58_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-12-8","volume":"12","author":"M Forss","year":"2012","unstructured":"Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency-a worldwide patient survey. BMC Endocr Disord. 2012;12(1):8.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"58_CR22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2008-2380","volume":"94","author":"M Debono","year":"2009","unstructured":"Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"58_CR23","doi-asserted-by":"crossref","unstructured":"Giordano R, Guaraldi F, Marinazzo E, Fumarola F, Rampino A, Berardelli R, et al. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison\u2019s disease. Endocrine 2015:1\u20139.","DOI":"10.1007\/s12020-015-0681-z"},{"issue":"3","key":"58_CR24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2014-3809","volume":"100","author":"A Mallappa","year":"2014","unstructured":"Mallappa A, Sinaii N, Kumar P, Whitaker MJ, Daley L-A, Digweed D, et al. A phase 2 study of chronocort\u00ae, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2014;100(3):1137\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"58_CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-09-0170","volume":"161","author":"G Johannsson","year":"2009","unstructured":"Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol. 2009;161(1):119\u201330.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"58_CR26","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2013-4253","volume":"99","author":"M \u00d8ksnes","year":"2014","unstructured":"\u00d8ksnes M, Bj\u00f6rnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, et al. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: a randomized clinical trial. J Clin Endocrinol Metab. 2014;99(5):1665\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"58_CR27","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1210\/jc.2014-2433","volume":"99","author":"L Gagliardi","year":"2014","unstructured":"Gagliardi L, Nenke MA, Thynne TR, von der Borch J, Rankin WA, Henley DE, et al. Continuous subcutaneous hydrocortisone infusion therapy in Addison\u2019s disease: a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2014;99(11):4149\u201357.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"58_CR28","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","volume":"94","author":"AA Alkatib","year":"2009","unstructured":"Alkatib AA, Cosma M, Elamin MB, Erickson D, Swiglo BA, Erwin PJ, et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab. 2009;94(10):3676\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"58_CR29","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1210\/jc.2011-0015","volume":"96","author":"S Hsieh","year":"2011","unstructured":"Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab. 2011;96(6):E925\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"58_CR30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-08-1003","volume":"160","author":"U Elbelt","year":"2009","unstructured":"Elbelt U, Hahner S, Allolio B. Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy. Eur J Endocrinol. 2009;160(6):919\u201324.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"58_CR31","first-page":"3082","volume":"84","author":"L Plat","year":"1999","unstructured":"Plat L, Leproult R, L\u2019Hermite-Baleriaux M, Fery F, Mockel J, Polonsky KS, et al. Metabolic effects of short-term elevations of plasma cortisol Are more pronounced in the evening than in the morning 1. J Clin Endocrinol Metab. 1999;84(9):3082\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"58_CR32","first-page":"2468","volume":"81","author":"E Cauter Van","year":"1996","unstructured":"Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996;81(7):2468\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"58_CR33","first-page":"E36","volume":"270","author":"L Plat","year":"1996","unstructured":"Plat L, Byrne MM, Sturis J, Polonsky KS, Mockel J, Fery F, et al. Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am J Physiol. 1996;270(1):E36\u201342.","journal-title":"Am J Physiol"},{"issue":"5","key":"58_CR34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/dia.2011.0158","volume":"14","author":"G Meyer","year":"2012","unstructured":"Meyer G, Hackemann A, Reusch J, Badenhoop K. Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison\u2019s disease). Diabetes Technol Ther. 2012;14(5):386\u20138.","journal-title":"Diabetes Technol Ther"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-015-0058-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T17:58:35Z","timestamp":1567274315000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-015-0058-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1186\/s12902-015-0058-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,24]]},"article-number":"61"}}